ACE2 |
Angiotensin-Converting Enzyme 2 |
ACovCS |
Acute COVID-19 Cardiovascular Syndrome |
AKI |
Acute Kidney Injury |
ALT |
Alanine Aminotransferase |
ARDS |
Acute Respiratory Distress Syndrome |
AST |
Aspartate Aminotransferase |
BBB |
Blood–brain barrier |
BUN |
Blood Urea Nitrogen |
CD4 |
Cluster of Differentiation 4 |
CD8 |
Cluster of Differentiation 8 |
CKD |
Chronic Kidney Disease |
CNS |
Central Nervous System |
COVID-19 |
Coronavirus Disease 2019 |
DIC |
Disseminated Intravascular Coagulation |
FDA |
Food and Drug Administration |
FiO2
|
Percentage of inspired oxygen |
IFN-γ |
Interferon Gamma |
IL-1 |
Interleukin 1 |
IL-1RA |
Interleukin Receptor type 1 |
IL-6 |
Interleukin 6 |
IP-10 |
Interferon Inducible Cytokine IP10 |
MCP-1 |
Monocyte Chemoattractant Protein 1 |
MIP-1 |
Macrophage Inflammatory Protein 1-α |
MSCs |
Mesenchymal Stem Cells |
NK |
Natural Killer |
NRF2 |
Nuclear factor erythroid 2-Related Factor 2 |
PaO2
|
Partial Pressure of arterial oxygen |
PNS |
Peripheral Nervous System |
ROS |
Reactive oxygen species |
SARS-CoV-2 |
Severe Acute Respiratory Syndrome CoronaVirus 2 |
TNF-α |
Tumor Necrosis Factor-alpha |